Evidence map›Paper›PMID 34630863›Full record

ReviewWorld journal of stem cells2021

Empty nose syndrome pathogenesis and cell-based biotechnology products as a new option for treatment.

Inna M Gordiienko, Olga S Gubar, Roman Sulik, Taras Kunakh, Igor Zlatskiy, Alona Zlatska

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of stem cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Surgical interventions for empty nose syndrome: A meta-analysis of meta-analyses.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Pooled it
  3. Trial
  4. From Dry Cavities to Healing Pathways: Innovations in Managing Empty Nose Syndrome.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Inna M GordiienkoBiotechnology Laboratory, Medical Company "Good Cells", Kyiv 03115, Ukraine.
Olga S GubarInstitute of Molecular Biology and Genetics NAS of Ukraine, Kyiv 03143, Ukraine.
Roman SulikBiotechnology Laboratory, Medical Company "Good Cells", Kyiv 03115, Ukraine.
Taras KunakhBiotechnology Laboratory, Medical Company "Good Cells", Kyiv 03115, Ukraine.
Igor ZlatskiyState Institute of Genetic and Regenerative Medicine, National Academy of Medical Sciences of Ukraine, Kyiv 04114, Ukraine. zlatskiy@ukr.net.
Alona ZlatskaBiotechnology Laboratory, Medical Company "Good Cells", Kyiv 03115, Ukraine.
Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine · UAR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Empty nose syndrome (ENS) is a rare complication that develops after partial or complete turbinectomy. The main feature of ENS is paradoxical nasal obstruction feeling despite objectively wide nasal airway. ENS pathogenesis is multifactorial and includes changes in laminar physiological airflow, disruption of mucosa functions and deficient neural sensation. This leads to the development of ENS symptomatology such as dyspnea, nasal dryness, nasal burning, nasal obstruction, feeling of suffocation and even comorbid psychiatric disorders that significantly impairs life quality. Specific effective treatment of ENS does not exist up to date. In this review we outline existing biomaterial for surgical reconstitution of nasal anatomy and discuss the perspective of stem cell-based technologies in ENS management. The main focus is directed to justification of rationality application of adult mesenchymal stem cells (MSCs) from different tissues origin and neural crest-derived stem cells (NCSCs) based on their intrinsic biological properties. MSCs transplantation may stimulate mucosa tissue regeneration

Indexed as

Empty nose syndromeGraftsHydrogelsImplants biomaterialsMesenchymal stem cellsStem-cell-based technologies

Identifiers

PMID34630863
PMCPMC8474723
OpenAlexW3199747946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.